Apr 29, 2015
In spite of aggressive chemotherapy treatments, advanced prostate cancers have proven to be quite difficult to treat. As a heterogeneous mass of different cancerous mutations, prostate tumors often evade cellular death, and have even been known to accumulate cells capable of suppressing a body’s immunological defenses. But in a new study published this week in the journal Nature, researchers have found that chemotherapy, when paired with immunotherapy, is a potent duo that has already proven successful in achieving prostate cancer remission in mouse models—now they think that the strategy may be ready to treat humans.
2. 10:57 PM
25 cups of coffee a day is still safe, experts say
3. 10:44 PM
France’s Solar Panel Road Deemed a Complete Failure
4. Aug 16, 2019
NASA Pinpointed Japan's Tropical Storm Before Landfall